We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+37.69%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$7.48B
AUM Growth
+$1.44B
Cap. Flow
-$77.6M
Cap. Flow %
-1.04%
Top 10 Hldgs %
23.83%
Holding
336
New
58
Increased
161
Reduced
69
Closed
35
Avg Time Held
6.6 quarters
Top 10 Avg Time Held
4.2 quarters
Top 20 Avg Time Held
4.6 quarters

Top Buys

Rank Stock Value
1
AVLN icon
Avalyn Pharma
AVLN
+$39.7M
2
CDNS icon
Cadence Design Systems
CDNS
+$29.6M
3
RELY icon
Remitly
RELY
+$27.3M
4
DELL icon
Dell
DELL
+$25.5M
5
FITB icon
Fifth Third Bancorp
FITB
+$25.3M

Top Sells

Rank Stock Value
1
XMTR icon
Xometry
XMTR
+$57.8M
2
PLD icon
Prologis
PLD
+$56.1M
3
GH icon
Guardant Health
GH
+$44M
4
AXSM icon
Axsome Therapeutics
AXSM
+$44M
5
GLBE icon
Global E Online
GLBE
+$37.6M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Technology 22.57%
3 Industrials 20.48%
4 Energy 5.51%
5 Utilities 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GH icon
1
Guardant Health
GH
$22B
$294M 3.93%
1,957,828
-404,551
-17% -$44M
2021 Q3
19 quarters
LRCX icon
2
Lam Research
LRCX
$375B
$292M 3.9%
673,431
-14,971
-2% -$4.54M
2015 Q1
45 quarters
XMTR icon
3
Xometry
XMTR
$6.3B
$208M 2.78%
2,151,845
-808,394
-27% -$57.8M
2021 Q2
20 quarters
TT icon
4
Trane Technologies
TT
$104B
$203M 2.72%
415,039
+8,484
+2% +$3.97M
2019 Q1
29 quarters
MIRM icon
5
Mirum Pharmaceuticals
MIRM
$5.31B
$146M 1.95%
1,248,389
-160,482
-11% -$16.1M
2022 Q3
15 quarters
ASML icon
6
ASML
ASML
$655B
$136M 1.82%
68,410
+300
+0.4% +$478K
2013 Q4
50 quarters
TRGP icon
7
Targa Resources
TRGP
$62.5B
$132M 1.76%
490,719
-11,568
-2% -$2.97M
2022 Q1
17 quarters
ODFL icon
8
Old Dominion Freight Line
ODFL
$37.6B
$130M 1.74%
599,458
+7,767
+1% +$1.68M
2019 Q3
27 quarters
GEV icon
9
GE Vernova
GEV
$265B
$125M 1.67%
106,999
-26,201
-20% -$26.7M
2024 Q4
6 quarters
URI icon
10
United Rentals
URI
$66B
$117M 1.57%
103,445
+5,650
+6% +$5.38M
2025 Q1
5 quarters
ARGX icon
11
argenx
ARGX
$50.5B
$117M 1.56%
125,668
+11
+0% +$9.07K
2018 Q1
33 quarters
SRRK icon
12
Scholar Rock
SRRK
$5.03B
$116M 1.55%
2,111,410
-85,975
-4% -$4.15M
2023 Q4
10 quarters
IRTC icon
13
iRhythm Holdings
IRTC
$3.53B
$105M 1.4%
880,338
+119,513
+16% +$13.9M
2022 Q2
16 quarters
KLAC icon
14
KLA
KLAC
$240B
$101M 1.35%
339,253
-57,137
-14% -$11.3M
2019 Q4
26 quarters
BBNX icon
15
Beta Bionics
BBNX
$970M
$98.1M 1.31%
6,253,673
+308,185
+5% +$3.67M
2025 Q1
5 quarters
LSCC icon
16
Lattice Semiconductor
LSCC
$17.1B
$93.5M 1.25%
611,272
+134
+0% +$17.3K
2020 Q3
23 quarters
NVT icon
17
nVent Electric
NVT
$26B
$90.6M 1.21%
536,108
+12,551
+2% +$1.96M
2021 Q2
20 quarters
GNRC icon
18
Generac Holdings
GNRC
$12.5B
$89.8M 1.2%
306,850
+12
+0% +$3.01K
2025 Q4
2 quarters
DDOG icon
19
Datadog
DDOG
$103B
$89M 1.19%
342,324
+102,489
+43% +$19.1M
2019 Q3
27 quarters
PANW icon
20
Palo Alto Networks
PANW
$329B
$85.7M 1.14%
251,535
-616
-0.2% -$141K
2013 Q4
50 quarters
ETR icon
21
Entergy
ETR
$49.9B
$83.9M 1.12%
728,019
+45,172
+7% +$5.09M
2024 Q4
6 quarters
PCVX icon
22
Vaxcyte
PCVX
$10.8B
$80.2M 1.07%
1,380,219
+5,927
+0.4% +$322K
2023 Q3
11 quarters
MPWR icon
23
Monolithic Power Systems
MPWR
$64.5B
$79.7M 1.07%
57,790
-364
-0.6% -$547K
2020 Q3
23 quarters
VST icon
24
Vistra
VST
$54B
$79.4M 1.06%
499,466
+6,755
+1% +$1.05M
2023 Q3
11 quarters
DELL icon
25
Dell
DELL
$365B
$79.3M 1.06%
185,502
+88,309
+91% +$25.5M
2024 Q3
7 quarters

Similar funds

Eventide Asset Management's Q2 2026 Portfolio in Review

As of Q2 2026, Eventide Asset Management held 336 positions worth $7.48B, up 24% from $6.05B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q2 2026 filing shows 58 new, 161 increased, 69 reduced and 35 closed positions. Its largest new stake was Avalyn Pharma: 1,375,486 shares worth $45.3M. The largest sale was Xometry, an estimated $57.8M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q2 2026 buy was Avalyn Pharma: 1,375,486 shares worth $45.3M.
  • Eventide Asset Management added most to Cadence Design Systems in Q2 2026, an estimated $29.6M increase.
  • Eventide Asset Management's biggest Q2 2026 reduction was Xometry, cutting an estimated $57.8M.
  • Eventide Asset Management fully exited Prologis in Q2 2026, selling an estimated $56.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $7.48B portfolio in Q2 2026.
  • Eventide Asset Management opened 58 new positions and closed 35 in Q2 2026.
  • Eventide Asset Management's portfolio value rose 24% quarter-over-quarter to $7.48B.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.